Ryan Acy
Senior Vice President, Corporate Affairs
Replay available
Revolution Medicines, Inc. (RVMD) Q2 2026 Earnings Call
Revolution Medicines, Inc. (NASDAQ: RVMD) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Mark Goldsmith
Chairman and Chief Executive Officer
Dr. Alan Sandler
Chief Development Officer
Jack Anders
Chief Financial Officer
Dr. Wei Lin
Chief Medical Officer
Anthony Mancini
Chief Global Commercialization Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Revolution Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.294 Good day and thank you for standing by. Welcome to the Revolution Medicines Q2 2026 00:00:05.294 -- 00:00:10.497 earnings conference call. At this time, all participants are in a listen-only mode. 00:00:10.497 -- 00:00:14.600 After the speaker's presentation, there will be a question and answer session. 00:00:14.600 -- 00:00:19.543 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:19.543 -- 00:00:23.265 You will then hear an automated message advising your hand is raised. 00:00:23.265 -- 00:00:27.442 To withdraw your question, please press star 1 1 again. 00:00:27.442 -- 00:00:30.883 Please be advised that today's conference is being recorded. 00:00:30.883 -- 00:00:35.645 I would now like to hand the conference over to your first speaker today, Ryan Acy, Senior 00:00:35.645 -- 00:00:40.365 Vice President, Corporate Affairs. Please go ahead. 00:00:43.387 -- 00:00:47.648 Thank you and welcome everyone to the second quarter 2026 earnings call. 00:00:47.648 -- 00:00:51.470 Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicines Chairman and 00:00:51.470 -- 00:00:56.524 Chief Executive Officer Dr. Alan Sandler, our Chief Development Officer, and 00:00:56.524 -- 00:00:59.226 Jack Anders, our Chief Financial Officer. Dr. 00:00:59.226 -- 00:01:04.049 Wei Lin, our Chief Medical Officer, and Anthony Mancini, our Chief Global Commercialization 00:01:04.049 -- 00:01:07.292 Officer, will join us for the Q&A portion of today's call. 00:01:07.292 -- 00:01:11.314 We would like to inform you that certain statements we make during this call will be 00:01:11.314 -- 00:01:15.277 forward-looking because such statements deal with future events and are subject to many 00:01:15.277 -- 00:01:20.2...